J. Regililbeau, Y. Panis, D. Parades, V. Marteau, P. Valleur et al., Manifestations anopérinéales dans la maladie de Crohn, Gastroenterol Clin Bi01, vol.24, pp.36-47, 2000.

D. Schwartz, E. Loftus, . Jr, W. Tremaine, R. Panaccione et al., The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota, Gastroenterology, vol.122, issue.4, pp.875-80, 2002.
DOI : 10.1053/gast.2002.32362

G. Hellers, O. Bergstrand, S. Ewesth, and B. Holmstrom, Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease., Gut, vol.21, issue.6, pp.525-532, 1980.
DOI : 10.1136/gut.21.6.525

. Rasul-1, S. Wilson, H. Macrae, S. Irwin, and G. Greenberg, Clinical and Radiological Responses after Infliximab Treatment for Perianal Fistulizing Crohn's Disease, The American Journal of Gastroenterology, vol.120, issue.1, pp.82-90, 2004.
DOI : 10.1056/NEJMoa020888

S. Ardizzone, G. Maconi, E. Colombo, G. Manzionna, S. Bollani et al., Perianal Fistulae Following Infliximab Treatment, Inflammatory Bowel Diseases, vol.17, issue.2, pp.91-97, 2004.
DOI : 10.1046/j.1365-2036.2003.01427.x

L. Siproudhis, A. Mostaji, J. Mary, F. Juguet, J. Bretagne et al., Anal lesions: any significant prognosis in Crohn??s disease?, European Journal of Gastroenterology & Hepatology, vol.9, issue.3, pp.239-282, 1997.
DOI : 10.1097/00042737-199703000-00004

R. Mckee and R. Keenan, Perianal Crohn??s disease???Is it all bad news?, Diseases of the Colon & Rectum, vol.39, issue.2, pp.136-178, 1996.
DOI : 10.1007/BF02068066

W. Conne11, J. Sheffield, M. Kamm, J. Ritchie, P. Hawley et al., Lower gastrointestinal malignancy in Crohn's disease, Gut, vol.35, pp.347-52, 1994.

M. Picco and T. Bayless, Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease, The American Journal of Gastroenterology, vol.122, issue.2, pp.363-371, 2003.
DOI : 10.1007/s00251-002-0440-1

I. Loftus, E. Jr, M. Silverstein, W. Sandborn, W. Trenlaine et al., Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival, Gut, vol.46, issue.3, pp.336-379, 2000.
DOI : 10.1136/gut.46.3.336

A. Ekbom, C. Helmick, M. Zack, L. Holmberg, and H. Adami, Survival and causes of death in patients with inflammatory bowel disease: A population-based study, Gastroenterology, vol.103, issue.3, pp.954-60, 1992.
DOI : 10.1016/0016-5085(92)90029-X

L. Hughes, Clinical classification of perianal Crohn??s disease, Diseases of the Colon & Rectum, vol.35, issue.10, pp.928-960, 1992.
DOI : 10.1007/BF02253493

J. Denis, R. Ganansia, T. Puy-montbrun, J. Denis, R. Ganansia et al., Lésions anales et péri-anales de la maladie de Crohn Proctologie pratique. 4" édition, pp.86-93, 1999.

O. Tissot, D. Bodnar, L. Henry, A. Dubreuil, and P. Valette, Ano-perineal fistula in MRI. Contribution of T2 weighted sequences, J Radio1, vol.77, pp.253-60, 1996.

P. Haggett, N. Moore, J. Shearman, S. Travis, D. Jewell et al., Pelvic and perineal complications of Crohn's disease: assessment using magnetic resonance imaging., Gut, vol.36, issue.3, pp.995407-995408
DOI : 10.1136/gut.36.3.407

P. Orsoni, M. Barthet, F. Portier, M. Panuel, A. Desjeux et al., Prospective comparison of endosonography, magnetic resonance imaging and surgical findings in anorectal fistula and abscess complicating Crohn's disease, British Journal of Surgery, vol.36, issue.3, pp.360-364, 1999.
DOI : 10.1007/BF02052266

O. Schaefer, C. Lohrinann, and M. Langer, Assessment of anal fistulas with high-resolution subtraction MR-fistulography: Comparison with surgical findings, Journal of Magnetic Resonance Imaging, vol.83, issue.1, pp.91-99, 2004.
DOI : 10.2214/ajr.171.2.9694464

G. Van-assche, D. Vailbeckevoort, D. Bielen, and G. Coreinaiîs, Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease, The American Journal of Gastroenterology, vol.98, issue.2, pp.332-341, 2003.
DOI : 10.1016/S0002-9270(02)05909-9

S. Ardizzone, G. Maconi, E. Colombo, G. Manzionna, S. Bollani et al., Perianal Fistulae Following Infliximab Treatment, Inflammatory Bowel Diseases, vol.17, issue.2, pp.91-97, 2004.
DOI : 10.1046/j.1365-2036.2003.01427.x

B. Ursing and C. Kamme, Metronidazole for Crohn's disease, Lancet, vol.1, pp.775-782, 19755.

L. Bernstein, M. Frank, L. Brandt, and S. Boley, Healing of perineal Crohil's disease with metronidazole, Gastroenterology, vol.79, p.599, 1980.

J. Jakobovits and M. Schuster, Metronidazole therapy for Crohn's disease and associated fistulae, Am J Gastroenterol, vol.79, pp.533-573, 1984.

R. Farmer, G. Whelan, and V. Fazio, Long-term follow-up of patients with Crohn's disease, Gastroenterology, vol.88, issue.6, pp.1818-1843, 1985.
DOI : 10.1016/0016-5085(85)90006-X

D. Schwartz, J. Pemberton, and W. Sandborn, Diagnosis and Treatment of Perianal Fistulas in Crohn Disease, Annals of Internal Medicine, vol.135, issue.10, pp.906-924, 2001.
DOI : 10.7326/0003-4819-135-10-200111200-00011

O. Schroder, . Blumenstein-1, A. Schulte-bockholt, and J. Stein, Combining inflixiniab and ~nethotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine

W. Sandborn, D. Present, K. Isaacs, D. Wolf, E. Greenberg et al., Tacrolimus for the treatment of fistulas in patients with crohn???s disease: a randomized, placebo-controlled trial, Gastroenterology, vol.125, issue.2, pp.380-388, 2003.
DOI : 10.1016/S0016-5085(03)00877-1

A. Lavy, G. Weisz, Y. Adir, Y. Raiilon, Y. Melained et al., Hyperbaric Oxygen for Perianal Crohn???s Disease, Journal of Clinical Gastroenterology, vol.19, issue.3, pp.202-207, 1994.
DOI : 10.1097/00004836-199410000-00006

D. Present, P. Rutgeerts, S. Targan, S. Hanauer, L. Mayer et al., Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease, New England Journal of Medicine, vol.340, issue.18, pp.1398-405, 1999.
DOI : 10.1056/NEJM199905063401804

B. Sands, F. Anderson, C. Bernstein, W. Chey, B. Feagan et al., Infliximab Maintenance Therapy for Fistulizing Crohn's Disease, New England Journal of Medicine, vol.350, issue.9, pp.876-85, 2004.
DOI : 10.1056/NEJMoa030815

L. Poritz, W. Rowe, and W. Koltun, Remicade?? Does Not Abolish the Need for Surgery in Fistulizing Crohn??s Disease, Diseases of the Colon & Rectum, vol.45, issue.6, pp.771-776, 2002.
DOI : 10.1007/s10350-004-6296-8

L. Linares, L. Moreira, H. Andrews, R. Allan, J. Alexander-williams et al., Natural history and treatment of anorectal strictures complicating Crohn's disease, British Journal of Surgery, vol.24, issue.7, pp.653-658, 1988.
DOI : 10.1001/jama.1957.02980010009003

J. Faucheron, O. Saint-marc, L. Guibert, and R. Parc, Long-term seton drainage for high anal fistulas in Crohn??s disease???A sphincter-saving operation?, Diseases of the Colon & Rectum, vol.39, issue.2, p.208, 1996.
DOI : 10.1007/BF02068077

T. Hammond, M. Grahn, and P. Lunniss, Fibrin glue in the management of anal fistulae, Colorectal Disease, vol.31, issue.5, pp.308-327, 2004.
DOI : 10.1046/j.1537-2995.2000.40030302.x

J. Sabate, J. Villarejo, M. Lemann, J. Bonnet, M. Allez et al., An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.24, issue.6, pp.1117-1141, 2002.
DOI : 10.2165/00002018-200124020-00002

T. Yamamoto, I. Bain, R. Allan, and M. Keighley, Persistent perineal sinus after proctocolectomy for Crohn??s disease, Diseases of the Colon & Rectum, vol.42, issue.1, pp.96-101, 1999.
DOI : 10.1007/BF02235190

M. Bigard and . Stomies-digestives, In: Bigard MA, traitement médical, endoscopique et chirurgical des inaladies du tube digestif. Issy-les-inoulineaux, pp.208-209, 2004.

J. Regiinbeau, Y. Panis, P. Marteau, S. Benoist, and P. Valleur, Surgical treatment of anoperineal Crohn???s disease: can abdominoperineal resection be predicted?11No competing interests declared., Journal of the American College of Surgeons, vol.189, issue.2, pp.171-177, 1999.
DOI : 10.1016/S1072-7515(99)00092-7

G. Guyatt, A. Mitchell, E. Irvine, J. Singer, N. Williams et al., A New Measure of Health Status for Clinical Trials in Inflammatory Bowel Disease, Gastroenterology, vol.96, issue.2, pp.804-814, 1989.
DOI : 10.1016/S0016-5085(89)80080-0

A. Allan, L. Linares, H. Spooner, A. , and J. , Clinical index to quantitate symptoms of perianal Crohn??s disease, Diseases of the Colon & Rectum, vol.35, issue.7, pp.656-61, 1992.
DOI : 10.1007/BF02053756

R. Harvey and J. Bradshaw, A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY, The Lancet, vol.315, issue.8167, p.514, 1980.
DOI : 10.1016/S0140-6736(80)92767-1

C. Delaney, R. Kiran, A. Senagore, B. O-'brien-ermlich, J. Church et al., Quality of life improves within 30 days of surgery for Crohn???s disease, Journal of the American College of Surgeons, vol.196, issue.5, pp.7-14, 2003.
DOI : 10.1016/S1072-7515(03)00131-5

F. Blondel-kucharski, C. Chircop, P. Marquis, A. Cortot, F. Baron et al., Health-related quality of life in Crohn's disease: a prospective longitudinal study in 231 patients, The American Journal of Gastroenterology, vol.90, issue.221, pp.2915-2935, 2001.
DOI : 10.7326/0003-4819-114-6-451

R. Cohen, The quality of life in patients with Crohn's disease, Alimentary Pharmacology and Therapeutics, vol.114, issue.5, pp.1603-1612, 2002.
DOI : 10.1016/S0016-5085(98)70309-9

B. Feagan, S. Yan, M. Bala, W. Bao, and G. Lichtenstein, The effects of infliximab maintenance therapy on health-related quality of life, The American Journal of Gastroenterology, vol.93, issue.10, pp.2232-2240, 2003.
DOI : 10.1016/S0889-1591(02)00009-0

V. Cadahia, A. Garcia-carbonero, S. Vivas, D. Fuentes, P. Nino et al., Infliximab improves quality of life in the short-term in patients with fistulizing Crohn's disease in clinical practice, Revista Espa??ola de Enfermedades Digestivas, vol.96, issue.6, pp.369-74, 2004.
DOI : 10.4321/S1130-01082004000600002

T. Conroy, P. Rauch, and F. Guillemin, Qualité de vie chez les patients atteints de cancer colo-rectal, Gastroenterol Clin Bi01, vol.23, pp.489-50, 1999.